insights_auto
Why is KAPA down 10.66%?
Dive Deeperchevron_right
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
$0.47
arrow_downward
-10.66%(-0.056) 1D
$0.50
arrow_upward
+4.75% (+0.022)todayPre-market
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KAPA...
Open
$0.54
High
$0.54
Low
$0.47
Mkt. cap
1.60M
Avg. vol.
692.80K
Volume
2.80K
52-wk high
$7.70
52-wk low
$0.47
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
Open
$0.54
High
$0.54
Low
$0.47
Mkt. cap
1.60M
Avg. vol.
692.80K
Volume
2.80K
52-wk high
$7.70
52-wk low
$0.47
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
News stories
From web sources and news partners
FinancialContent
·
18 minutes ago
AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates
marketscreener.com
·
56 minutes ago
Midterms and mediation
Barron's
·
4 minutes ago
S&P 500 Futures Decline in Premarket Trading; Ascendis Pharma, Madrigal Pharmaceuticals Lead
Yahoo Finance
·
1 hour ago
2 S&P 500 stocks for long-term investors and 1 we avoid
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Websitekairospharma.com